Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

By C. Packard, D. O'reilly, M. Caslake, A. McMahon, Ian Ford, J. Cooney, C. Macphee, K. Suckling, M. Krishna, F. Wilkinson and 4 more. New England Journal of Medicine, 2000

779 citations recorded by the source corpus.

Subfields: Cancer Research, Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/401a35a746aff3d4f9a7b7fa9be055ba94680dd3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Chan
2. Shi-Hui Law
3. F. Parveen
4. Liang‐Yin Ke
5. Chu‐Huang Chen
6. G. Marathe

Citations in the corpus

• An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases (2019, background): “Overproduction of LPC can result from the overexpression or enhanced activity of enzymes such as lipoprotein-associated phospholipase A2 (Lp-PLA2) in circulation [28,29].”